Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer. Benjamin WJ, Feng AL, Heft Neal M, Bellile E, et al. Oral Oncol 2024;156:106917.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Benjamin WJ, Feng AL, Heft Neal M, Bellile E, et al. Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer. Oral Oncol 2024;156:106917.
PMID: 38945011